Exploring the Concept of In Vivo Guided Tissue Engineering by a Single-Stage Surgical Procedure in a Rodent Model.
Clara Ibel ChamorroSaid ZeiaiNikolai JuulOliver WillacyJinxing HuoJöns HilbornMagdalena FossumPublished in: International journal of molecular sciences (2022)
In severe malformations with a lack of native tissues, treatment options are limited. We aimed at expanding tissue in vivo using the body as a bioreactor and developing a sustainable single-staged procedure for autologous tissue reconstruction in malformation surgery. Autologous micro-epithelium from skin was integrated with plastically compressed collagen and a degradable knitted fabric mesh. Sixty-three scaffolds were implanted in nine rats for histological and mechanical analyses, up to 4 weeks after transplantation. Tissue integration, cell expansion, proliferation, inflammation, strength, and elasticity were evaluated over time in vivo and validated in vitro in a bladder wound healing model. After 5 days in vivo, we observed keratinocyte proliferation on top of the transplant, remodeling of the collagen, and neovascularization within the transplant. At 4 weeks, all transplants were fully integrated with the surrounding tissue. Tensile strength and elasticity were retained during the whole study period. In the in vitro models, a multilayered epithelium covered the defect after 4 weeks. Autologous micro-epithelial transplants allowed for cell expansion and reorganization in vivo without conventional pre-operative in vitro cell propagation. The method was easy to perform and did not require handling outside the operating theater.
Keyphrases
- cell therapy
- tissue engineering
- wound healing
- single cell
- minimally invasive
- bone marrow
- oxidative stress
- signaling pathway
- gene expression
- spinal cord injury
- gestational age
- platelet rich plasma
- vascular endothelial growth factor
- coronary artery bypass
- acute coronary syndrome
- coronary artery disease
- surgical site infection
- endothelial cells